Under construction – not a live service
Sign in
Enrolling by invitationNo phase

Follows children with juvenile inflammatory rheumatism over time

Follows children with juvenile arthritis to study treatment safety and benefit.

Key facts

Who runs it
Michaël Hofer
Where
Casablanca, MoroccoSee the siteAlso in 4 other countries, 44 sites
Trial code
Registry title
Juvenile Inflammatory Rheumatism (JIR) Cohorte
Status
Enrolling by invitation
People taking part
15,000 people, planned
Started
Jan 2014
Expected to end
Dec 2030
Type of study
Observational
Record updated
15 June 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for children and young people with juvenile inflammatory rheumatic diseases. They will be followed over time to see how well immune-suppressing and biological medicines work and how well they are tolerated.

Age
Disease began at 18 years old or younger.
Sex
All sexes can join.
Disease stage
Juvenile inflammatory rheumatic disease. No stage or severity is stated.

Main reasons for not taking part

  • No consent from the patient or the legal representative

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients with juvenile inflammatory diseases
  • Age at onset up to 18 years old
  • Consent according national codes of ethics and current laws

Who cannot take part

  • Non-consent from patients and/or legal representative

Where in Morocco

Also in 4 other countries, 44 sites

  • Hôpital Ibnou RochdCasablanca, MoroccoNo longer taking part

About the trial

What the trial wants to find out

The investigators created a cohort of patients with juvenile inflammatory rheumatisms with the purpose to follow them prospectively, and investigate the tolerance and efficacy of immunosuppresive and biological agents.

The group in the trial

  • Juvenile Inflammatory Rheumatism

    Juvenile Inflammatory Rheumatism patients

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Setting up a Pediatric Cohort for Inflammatory Rheumatic Diseases
Plain-language title
Follows children with juvenile inflammatory rheumatism over timeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
15 June 2023